TexAu
Company Profile

How Much Did Tata 1mg Raise? Headquarters, Funding & Key Investors

Tata 1mg, founded in 2015 and headquartered in Delhi, became a unicorn in September 2022 with a $1.25 billion valuation. The company has raised $231 million across multiple funding rounds, including a $40.8 million Series D. Backed by investors such as HBM Healthcare Investments and supported by Tata Group, Tata 1mg operates an online pharmacy, doctor consultation, and diagnostic testing platform. The company focuses on improving access to affordable medicines, transparent pricing, and digital healthcare services across India.

Tata 1mg joined the Unicorn Club on Sep 06, 2022 after raising a $40.8M Series D funding round, valuing it at $1.25B.

Tata 1mg operates an online pharmacy and healthcare services platform. It enables users to browse medicines, compare prices, upload prescriptions, and purchase products online. The platform also provides doctor listings, teleconsultation services, and online lab test bookings. Additionally, Tata 1mg sells fitness supplements, healthcare products, medical devices, and alternative medicines, supporting end-to-end digital healthcare access.

Keep reading to understand Tata 1mg’s funding journey, investors, and growth trajectory.

What Is Tata 1mg and What Does It Do?

Founded in 2015, Tata 1mg is a digital healthcare platform offering online pharmacy services, doctor consultations, and diagnostic testing. The platform connects patients with verified doctors, laboratories, and pharmacies through a single interface.

Tata 1mg focuses on improving access to affordable medicines, transparent pricing, and convenient healthcare services through technology-driven solutions.

How Much Funding Has Tata 1mg Raised?

1. Series A Round

  • Amount Raised: ~$5 million
  • Date: 2016
  • Key Investors: Sequoia Capital India, Omidyar Network
  • Purpose: Scale operations and expand pharmacy and consultation services

2. Series B Round

  • Amount Raised: ~$20 million
  • Date: 2017
  • Key Investors: Sequoia Capital India, Omidyar Network
  • Purpose: Strengthen supply chain and grow nationwide presence

3. Series C Round

  • Amount Raised: ~$60 million
  • Date: 2019
  • Key Investors: Sequoia Capital India, HBM Healthcare Investments
  • Purpose: Expand diagnostics, technology, and healthcare partnerships

4. Series D Round

  • Amount Raised: $40.8 million
  • Date: Sep 02, 2022
  • Key Investors: Tata Group, HBM Healthcare Investments
  • Purpose: Scale integrated healthcare ecosystem and accelerate growth under Tata Group

Total Funding Raised: $231 million Latest Funding Date: Sep 02, 2022 Last Known Valuation: $1.25 billion Employee Count: 953

Key Investors

  1. HBM Healthcare Investments
    • Details: Global healthcare-focused investment firm
    • Focus Areas: Healthcare services, diagnostics, and life sciences
  2. Nuvama
    • Details: Investment and advisory firm with exposure to healthcare assets
    • Focus Areas: Healthcare, consumer platforms, and technology-led businesses
  3. Tata Group
    • Details: Indian multinational conglomerate and strategic acquirer
    • Focus Areas: Consumer, healthcare, digital platforms, and infrastructure

Where Is Tata 1mg’s Headquarters?

Tata 1mg is headquartered in Delhi, India, serving as the central hub for its digital healthcare operations and platform development.

What’s Next for Tata 1mg?

Tata 1mg is expected to deepen integration with Tata Group’s digital ecosystem, expand diagnostic and telehealth offerings, and strengthen last-mile medicine delivery across India.

Get Investor & Funding Insights with TexAu

TexAu helps you track verified funding rounds, valuations, and investor activity for companies like Tata 1mg.

Sign up for Free to access real-time investor and funding intelligence.

See your first enriched leads in 2 minutes

No credit card. No onboarding call. Just paste your list and watch it fill.

Up and running in 2 minutes. No credit card required.